Imipramine Crescent Pharma International (Imipramine Hydrochloride)

Imipramine blocks the reuptake of the neurotransmitters norepinephrine and serotonin at neuronal synapses. By preventing their removal, the drug raises their concentration in the central nervous system, enhancing neurotransmission that regulates mood, anxiety, and bladder function, which underlies its therapeutic effects.

The appropriate dose of imipramine is determined by the prescribing healthcare professional based on the individual’s condition, age, weight, and response to therapy. Dosage adjustments may be needed over time, and patients should follow the prescriber’s instructions without self‑adjusting the amount.

Safety data for imipramine in pregnancy and lactation are limited. Healthcare providers must weigh the potential benefits against possible risks to the fetus or infant. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss alternative treatments or close monitoring with their clinician.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Imipramine is a tricyclic antidepressant, differing from newer classes such as SSRIs and SNRIs in its mechanism and side‑effect profile. While effective for depression and anxiety, it often has more anticholinergic and cardiovascular effects, making it less commonly first‑line compared with newer agents that have more favorable tolerability.

Imipramine Crescent Pharma International should be stored at temperatures below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Imipramine is taken orally, usually in tablet form, with or without food as directed by the prescriber. The tablet should be swallowed whole with a glass of water and not chewed or crushed unless specifically instructed.

Serious risks include cardiac arrhythmias, especially in patients with pre‑existing heart disease, seizures, severe hypotension, hepatotoxicity, and the potential for worsening depression or suicidal thoughts, particularly at the start of therapy or when doses are changed.

Imipramine is contraindicated in patients with known hypersensitivity to the drug, recent myocardial infarction, uncontrolled narrow‑angle glaucoma, and those currently taking monoamine oxidase inhibitors. Caution is also advised for individuals with severe liver or kidney impairment, epilepsy, or a history of severe cardiac conduction disorders.